Sign Up Today and Learn More About SNIPR Biome Stock
Invest in or calculate the value of your shares in SNIPR Biome or other pre-IPO companies through EquityZen's platform.
SNIPR Biome Stock
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.
About SNIPR Biome Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
SNIPR Biome Press Mentions
Stay in the know about the latest news on SNIPR Biome
French startup Exeliom Biosciences boosts funding with €2.85 million to accelerate immunotherapy for cancer
eu-startups • Oct 22, 2025
CRISPR-based therapeutics hold potential to combat AMR
thepharmaletter • Aug 15, 2025
SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance
synbiobeta • Aug 15, 2025
CRISPR-based therapeutics hold potential to combat AMR and cure chronic viral infections, says GlobalData
pharmiweb • Aug 14, 2025
Danish BioTech scale-up SNIPR Biome raises €35 million to target antimicrobial resistance in diseases like cancer
eu-startups • Aug 09, 2025
SNIPR Biome Management
Leadership team at SNIPR Biome
Board Member
Christian E. Elling
Chief Business Officer
Stephanie Krebs
Join now and verify your accreditation status to gain access to:
- SNIPR Biome Current Valuation
- SNIPR Biome Stock Price
- SNIPR Biome Management
- Available deals in SNIPR Biome and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- SNIPR Biome Cap Table and Funding History by Share Class and Liquidity Preferences
- SNIPR Biome Revenue and Financials
- SNIPR Biome Highlights
- SNIPR Biome Business Model
- SNIPR Biome Risk Factors
- SNIPR Biome Research Report from SACRA Research
Trading SNIPR Biome Stock
How to invest in SNIPR Biome stock?
Accredited investors can buy pre-IPO stock in companies like SNIPR Biome through EquityZen funds. These investments are made available by existing SNIPR Biome shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell SNIPR Biome stock?
Shareholders can sell their SNIPR Biome stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."